Richard Paul Bryce, Title of Reporting Person: Chief Medical and Scien at Puma Biotechnology, holds 121.66K shares in Puma Biotechnology (Ticker: PBYI), holds ― shares in Rain Oncology (Ticker: RAIN), holds ― shares in enGene Holdings (Ticker: ENGN). Most recently, Richard Paul Bryce Sold ― shares of Puma Biotechnology on Apr 06, 2021 for an estimated value of 4.17K.